Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$1.46 - $7.3 $33,131 - $165,658
22,693 New
22,693 $36,000
Q2 2018

Aug 06, 2018

SELL
$36.2 - $76.4 $167,859 - $354,266
-4,637 Closed
0 $0
Q1 2018

May 08, 2018

SELL
$65.94 - $80.76 $153,244 - $187,686
-2,324 Reduced 33.39%
4,637 $335,000
Q4 2017

Feb 06, 2018

BUY
$43.47 - $67.43 $302,594 - $469,380
6,961
6,961 $458,000

Others Institutions Holding ESPR

About Esperion Therapeutics, Inc.


  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $168M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Teacher Retirement System Of Texas Portfolio

Follow Teacher Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.